Quantum Labs
简体中文
PT-141 10 mg10 瓶装库存 6立省 25%
peptideintermediate库存 6

PT-141 10 mg

Bremelanotide 黑皮质素激动剂

PT-141 bremelanotide research peptide, Australian-shipped. Lab-verified ≥99% purity.

剂量
10mg / 瓶
剂型
冻干粉末
包装
10 瓶装

仅供研究使用。 本化合物严格用于体外研究及实验室用途,不得用于人体食用或治疗用途。购买即确认您为合格研究者,并同意我们的 完整免责声明。

¥988 CNY
立省 25%
10 瓶装
原价 ¥1,316 CNY
以 10 瓶装出售

仅剩 6 盒

🧪实验室验证
✓第三方检测
⚡全球快速配送
🔒安全银行卡支付
概览

合成黑皮质素受体激动剂,文献关注其对与性反应相关神经通路的影响(研究应用)。

PT-141 (bremelanotide) is a synthetic melanocortin-receptor agonist derived from the alpha-melanocyte-stimulating hormone (α-MSH) family. It is one of the most studied melanocortin-pathway research peptides outside of the tanning-active analogues. Quantum Labs supplies PT-141 as a lyophilised powder for Australian research applications.

Research on PT-141 has covered the central melanocortin pathway, particularly MC3R and MC4R receptor activation, and pre-clinical models of sexual-response signalling. Material is HPLC-verified to ≥99% purity and ships from Australian stock; supplied for laboratory research use only.

作用机制

研究提示其主要激动 MC4R,并对受试对象中枢神经系统的神经化学指标产生影响。

实验室报告

经 HPLC 验证,纯度规格 ≥99%。由获认可的第三方实验室独立检测。

研究者常见问题

PT-141 — 常见问题

What is PT-141?

PT-141 (bremelanotide) is a synthetic melanocortin-receptor agonist studied in research models of central melanocortin-pathway signalling. It is one of the most-studied research peptides in the melanocortin family alongside the tanning-active analogues.

Is PT-141 legal in Australia?

PT-141 is restricted for compounded human therapeutic supply in Australia and remains available for research and laboratory use when supplied without therapeutic representation. Quantum Labs supplies PT-141 for research use only.

What receptors does PT-141 target?

PT-141 primarily activates the melanocortin-3 (MC3R) and melanocortin-4 (MC4R) receptors. Research has focused on the central melanocortin pathway, particularly downstream signalling in MC4R-rich brain regions.

What is bremelanotide?

Bremelanotide is the generic name for PT-141. It is a cyclic synthetic peptide derived from the α-MSH lineage. PT-141 is the research-code designation; bremelanotide is the pharmaceutical name.

What is the typical PT-141 research dosage?

Published research protocols have used wide dose ranges depending on the model and delivery route (intranasal, subcutaneous). Human dosing is not established. Researchers should consult primary literature for protocol-specific guidance.

延伸阅读

与 PT-141 相关的指南

相关化合物

研究者还会浏览